{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:59:00Z","timestamp":1773521940866,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Limburg Clinical Research Center"},{"DOI":"10.13039\/100022919","name":"Limburgs Kankerfonds","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100022919","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-026-04852-1","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:44:01Z","timestamp":1773474241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the efficacy of photobiomodulation therapy in the management of chemotherapy-induced peripheral neuropathy: a pilot trial (NEUROLIGHT trial)"],"prefix":"10.1007","volume":"41","author":[{"given":"Marith\u00e9","family":"Claes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Lodewijckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien","family":"Robijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Mebis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"6","key":"4852_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4852_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust T\u00c5 et al (2019) Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol 20(11):1493\u20131505","journal-title":"Lancet Oncol"},{"issue":"2","key":"4852_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A et al (2021) Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther 9(2):385\u2013450","journal-title":"Oncol Ther"},{"issue":"3","key":"4852_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12032-023-01954-6","volume":"40","author":"LSH Brianna","year":"2023","unstructured":"Brianna LSH (2023) Chemotherapy: how to reduce its adverse effects while maintaining the potency? Med Oncol 40(3):88","journal-title":"Med Oncol"},{"issue":"12","key":"4852_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","volume":"6","author":"G Cavaletti","year":"2010","unstructured":"Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6(12):657\u2013666","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"4852_CR6","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone KM, Horak F, Jacobs PG, Trubowitz P, Dieckmann NF, Stoyles S et al (2017) Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy. J Clin Oncol 35(23):2604\u20132612","journal-title":"J Clin Oncol"},{"issue":"2","key":"4852_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","volume":"159","author":"T Bao","year":"2016","unstructured":"Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327\u2013333","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"4852_CR8","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 155(12):2461\u20132470","journal-title":"Pain"},{"issue":"10","key":"4852_CR9","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306\u20131319","journal-title":"Ann Oncol"},{"issue":"28","key":"4852_CR10","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL et al (2020) Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 38(28):3325\u20133348","journal-title":"J Clin Oncol"},{"issue":"7","key":"4852_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.5603\/GP.2016.0036","volume":"87","author":"D Izycki","year":"2016","unstructured":"Izycki D, Niezgoda AA, Kazmierczak M, Piorunek T, Izycka N, Karaszewska B et al (2016) Chemotherapy-induced peripheral neuropathy - diagnosis, evolution and treatment. Ginekol Pol 87(7):516\u2013521","journal-title":"Ginekol Pol"},{"issue":"4","key":"4852_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00280-014-2607-5","volume":"75","author":"E Rivera","year":"2015","unstructured":"Rivera E, Cianfrocca M (2015) Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemother Pharmacol 75(4):659\u2013670","journal-title":"Cancer Chemother Pharmacol"},{"key":"4852_CR13","doi-asserted-by":"crossref","unstructured":"de Freitas LF, Hamblin MR (2016) Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron 22(3)","DOI":"10.1109\/JSTQE.2016.2561201"},{"key":"4852_CR14","doi-asserted-by":"crossref","unstructured":"Abijo A, Lee CY, Huang CY, Ho PC, Tsai KJ (2023) The beneficial role of photobiomodulation in neurodegenerative diseases. Biomedicines 11(7)","DOI":"10.3390\/biomedicines11071828"},{"issue":"4","key":"4852_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10103-017-2186-x","volume":"32","author":"ALM de Andrade","year":"2017","unstructured":"de Andrade ALM, Bossini PS, De do C, Sanchez ALM, Parizotto AD (2017) NA. Effect of photobiomodulation therapy (808 nm) in the control of neuropathic pain in mice. Lasers Med Sci 32(4):865\u2013872","journal-title":"Lasers Med Sci"},{"issue":"5","key":"4852_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/php.13415","volume":"97","author":"GML Della Santa","year":"2021","unstructured":"Della Santa GML, Ferreira MC, Machado TPG, Oliveira MX, Santos AP (2021) Effects of Photobiomodulation Therapy (LED 630 nm) on Muscle and Nerve Histomorphometry after Axonotmesis. Photochem Photobiol 97(5):1116\u20131122","journal-title":"Photochem Photobiol"},{"key":"4852_CR17","doi-asserted-by":"crossref","unstructured":"Lodewijckx J, Robijns J, Claes M, Evens S, Swinnen L, Lenders H et al (2022) The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomised, placebo-controlled pilot trial (NEUROLASER trial). Support Care Cancer 1\u20139","DOI":"10.1007\/s00520-023-07743-1"},{"issue":"1","key":"4852_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11845-013-0971-5","volume":"183","author":"S Vasquez","year":"2014","unstructured":"Vasquez S, Guidon M, McHugh E, Lennon O, Grogan L, Breathnach OS (2014) Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice. Ir J Med Sci 183(1):53\u201358","journal-title":"Ir J Med Sci"},{"issue":"3","key":"4852_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01893697-201533030-00004","volume":"33","author":"MI Fisher","year":"2015","unstructured":"Fisher MI, Lee J, Davies CC, Geyer H, Colon G, Pfalzer L (2015) Oncology Section EDGE Task Force on Breast Cancer Outcomes: A Systematic Review of Outcome Measures for Functional Mobility. Rehabilitation Oncol 33(3):19\u201331","journal-title":"Rehabilitation Oncol"},{"issue":"9","key":"4852_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/thoraxjnl-2014-205228","volume":"69","author":"E Beekman","year":"2014","unstructured":"Beekman E, Mesters I, Gosselink R, Klaassen MP, Hendriks EJ, Van Schayck OC et al (2014) The first reference equations for the 6-minute walk distance over a 10 m course. Thorax 69(9):867\u2013868","journal-title":"Thorax"},{"issue":"3","key":"4852_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/01893697-201533030-00005","volume":"33","author":"E Hile","year":"2015","unstructured":"Hile E, Levangie P, Ryans K, Gilchrist L (2015) Oncology Section Task Force on Breast Cancer Outcomes: Clinical Measures of Chemotherapy-induced Peripheral Neuropathy\u2014A Systematic Review. Rehabilitation Oncol 33(3):32\u201341","journal-title":"Rehabilitation Oncol"},{"issue":"2","key":"4852_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A et al (2021) Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther 9(2):385\u2013450","journal-title":"Oncol Ther"},{"issue":"8","key":"4852_CR23","first-page":"4223","volume":"29","author":"C Maihofner","year":"2021","unstructured":"Maihofner C, Diel I, Tesch H, Quandel T, Baron R (2021) Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin. Support Care Cancer 29(8):4223\u20134238","journal-title":"Support Care Cancer"},{"issue":"1","key":"4852_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2016.11.013","volume":"144","author":"PA Argenta","year":"2017","unstructured":"Argenta PA, Ballman KV, Geller MA, Carson LF, Ghebre R, Mullany SA et al (2017) The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomised, sham-controlled clinical trial. Gynecol Oncol 144(1):159\u2013166","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4852_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/acupmed-2016-011112","volume":"34","author":"YL Hsieh","year":"2016","unstructured":"Hsieh YL, Chou LW, Hong SF, Chang FC, Tseng SW, Huang CC et al (2016) Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study. Acupunct Med 34(5):398\u2013405","journal-title":"Acupunct Med"},{"issue":"4","key":"4852_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11764-019-00769-7","volume":"13","author":"JM McCrary","year":"2019","unstructured":"McCrary JM, Goldstein D, Wyld D, Henderson R, Lewis CR, Park SB (2019) Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. J Cancer Surviv 13(4):495\u2013502","journal-title":"J Cancer Surviv"},{"issue":"3","key":"4852_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/wvn.12672","volume":"21","author":"CL Li","year":"2024","unstructured":"Li CL, Chen PY, Yang TY, Chang JT, Tang WR, Chen ML (2024) Changes in fatigue among cancer patients before, during, and after radiation therapy: A meta-analysis. Worldviews Evid Based Nurs 21(3):234\u2013244","journal-title":"Worldviews Evid Based Nurs"},{"issue":"1","key":"4852_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12955-020-01493-y","volume":"18","author":"HL Cheng","year":"2020","unstructured":"Cheng HL, Lopez V, Lam SC, Leung AKT, Li YC, Wong KH et al (2020) Psychometric testing of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-Neurotoxicity (FACT\/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Health Qual Life Outcomes 18(1):246","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"4852_CR29","first-page":"52","volume":"31","author":"C Teng","year":"2022","unstructured":"Teng C, Egger S, Blinman PL, Vardy JL (2022) Evaluating laser photobiomodulation for chemotherapy-induced peripheral neuropathy: a randomised phase II trial. Support Care Cancer 31(1):52","journal-title":"Support Care Cancer"},{"issue":"2","key":"4852_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.6004\/jnccn.2023.7083","volume":"22","author":"FM Mahfouz","year":"2024","unstructured":"Mahfouz FM, Li T, Timmins HC, Horvath LG, Harrison M, Grimison P et al (2024) Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity. J Natl Compr Canc Netw 22(2):108\u2013116","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"4852_CR31","first-page":"5933","volume":"28","author":"CS Bonhof","year":"2020","unstructured":"Bonhof CS, Trompetter HR, Vreugdenhil G, van de Poll-Franse LV, Mols F (2020) Painful and nonpainful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry. Support Care Cancer 28(12):5933\u20135941","journal-title":"Support Care Cancer"},{"issue":"2","key":"4852_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11764-021-01012-y","volume":"16","author":"HC Timmins","year":"2022","unstructured":"Timmins HC, Li T, Goldstein D, Trinh T, Mizrahi D, Harrison M et al (2022) The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors. J Cancer Surviv 16(2):223\u2013232","journal-title":"J Cancer Surviv"},{"issue":"3","key":"4852_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ (2015) Body Mass Index: Obesity, BMI, and Health: A Critical Review. Nutr Today 50(3):117\u2013128","journal-title":"Nutr Today"},{"issue":"5","key":"4852_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4103\/ijmr.IJMR_1777_18","volume":"148","author":"R Kuriyan","year":"2018","unstructured":"Kuriyan R (2018) Body composition techniques. Indian J Med Res 148(5):648\u2013658","journal-title":"Indian J Med Res"},{"key":"4852_CR35","doi-asserted-by":"publisher","first-page":"927685","DOI":"10.3389\/fonc.2022.927685","volume":"12","author":"J Robijns","year":"2022","unstructured":"Robijns J, Nair RG, Lodewijckx J, Arany P, Barasch A, Bjordal JM et al (2022) Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front Oncol 12:927685","journal-title":"Front Oncol"},{"issue":"6","key":"4852_CR36","doi-asserted-by":"publisher","first-page":"e01312","DOI":"10.1002\/brb3.1312","volume":"9","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis A, Cheng HL, Leung KT, Li YC, Wong KH, Au JSK et al (2019) Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Brain Behav 9(6):e01312","journal-title":"Brain Behav"},{"key":"4852_CR37","doi-asserted-by":"crossref","unstructured":"Gordon-Williams R, Farquhar-Smith P (2020) Recent advances in understanding chemotherapy-induced peripheral neuropathy. F1000Res 9","DOI":"10.12688\/f1000research.21625.1"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04852-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04852-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04852-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:02:27Z","timestamp":1773518547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04852-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4852"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04852-1","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}